MacroHint

MacroHint

Stock Analysis: Regeneron Pharmaceuticals (NASDAQ: REGN)

About Regeneron Pharmaceuticals For whatever reason, pharmaceutical companies and their stocks have been the word on the street at MacroHint. Regeneron is by no means an exception. Aside from having a name that sounds like one of the lost members of the Transformer’s, at its core Regeneron is a serious disease company, essentially focused on

Stock Analysis: Regeneron Pharmaceuticals (NASDAQ: REGN) Read More »